{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:22:31Z","timestamp":1770682951482,"version":"3.49.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>The treatment of volume overload has vexed physicians for centuries. References to herbal remedies for the treatment of fluid retention date as far back as 1550 BC in the Ebers Papyrus from Ancient Egypt [1]. The term edema originates from the Greek \u201cto swell,\u201d and the Greek hero Oedipus, meaning \u201cswollen foot,\u201d was so named due to the swelling of his feet from injuries inflicted by his mother to prevent the fulfillment of a prophecy. There are several references to edema in the writings of Hippocrates, with various proposed treatments, ranging from herbal remedies, purgatives, phlebotomy, and cranial decompression. The word dropsy, from the Greek word for water, originated in the Middle English period and came to describe conditions associated with an accumulation of fluid in body tissue, preceding more sophisticated knowledge of distinctive disease states. Physicians often prescribed treatments such as bloodletting, purgatives, leeches, and Southey tubes, which were invented in 1877 by English physician Reginald Southey. These were small cannulas placed in a patient\u2019s swollen extremities to relieve edema, used until the 1960s [2]. It was not until the serendipitous discovery of the diuretic properties of the mercurial agent Novasurol by Alfred Vogl, while working as a medical student at the Wenckebach clinic in Vienna, used to treat a young patient with congenital syphilis [3], that spurred the interest in synthetic diuretic agents. Despite being the first agent synthesized, acetazolamide became the \u201cforgotten diuretic\u201d until a recent resurgence has reinvigorated interest in its utility in patients with acute decompensated heart failure. This review will describe the background, clinical trials, and proposed utility of acetazolamide in states of volume overload.<\/jats:p>","DOI":"10.1093\/ckj\/sfaf379","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T13:22:58Z","timestamp":1764768178000},"source":"Crossref","is-referenced-by-count":0,"title":["Use of acetazolamide in volume overload: start at the beginning"],"prefix":"10.1093","volume":"19","author":[{"given":"Nayan","family":"Arora","sequence":"first","affiliation":[{"name":"Oregon Health & Science University Division of Nephrology & Hypertension, Department of Medicine, , Portland, OR ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2915-265X","authenticated-orcid":false,"given":"David H","family":"Ellison","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University Division of Nephrology & Hypertension, Department of Medicine, , Portland, OR ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"key":"2026020903164224900_bib1","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.cardfail.2006.03.001","article-title":"Ancient Egyptian medicine and the concept of heart failure","volume":"12","author":"Saba","year":"2006","journal-title":"J Card Fail"},{"key":"2026020903164224900_bib2","first-page":"45","article-title":"The use of Southey tubes in the treatment of edema","volume":"4","author":"FIESE","year":"1946","journal-title":"Stanford Med Bull"},{"key":"2026020903164224900_bib3","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/0002-8703(50)90299-7","article-title":"The discovery of the organic mercurial diuretics","volume":"39","author":"VOGL","year":"1950","journal-title":"Am Heart J"},{"key":"2026020903164224900_bib4","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/146164a0","article-title":"Sulphanilamide as specific inhibitor of carbonic anhydrase","volume":"146","author":"Mann","year":"1940","journal-title":"Nature"},{"key":"2026020903164224900_bib5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1056\/NEJM194902032400503","article-title":"The effect of sulfanilamide on salt and water excretion in congestive heart failure","volume":"240","author":"Schwartz","year":"1949","journal-title":"N Engl J Med"},{"key":"2026020903164224900_bib6","doi-asserted-by":"publisher","first-page":"4893","DOI":"10.1021\/ja01167a012","article-title":"Heterocyclic sulfonamides as carbonic anhydrase inhibitors","volume":"72","author":"Miller","year":"1950","journal-title":"J Am Chem Soc"},{"key":"2026020903164224900_bib7","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/0021-9681(55)90195-8","article-title":"A comparative study of neohydrin and diamox when used alone and in combination for the treatment of severe congestive heart failure","volume":"2","author":"Moyer","year":"1955","journal-title":"J Chronic Dis"},{"key":"2026020903164224900_bib8","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/0021-9681(55)90194-6","article-title":"A comparative study of mersoben, mercuhydrin (parenteral diuretics), neohydrin, and diamox (oral diuretics)","volume":"2","author":"Moyer","year":"1955","journal-title":"J Chronic Dis"},{"key":"2026020903164224900_bib9","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1056\/NEJM195405132501902","article-title":"Oral administration of a potent carbonic anhydrase inhibitor (\u201cDiamox\u201d). II. Its use as a diuretic in patients with severe congestive heart failure","volume":"250","author":"Relman","year":"1954","journal-title":"N Engl J Med"},{"key":"2026020903164224900_bib10","first-page":"583","article-title":"Observations on the pharmacology of the carbonic anhydrase inhibitor Diamox","volume":"13","author":"Counihan","year":"1954","journal-title":"Clin Sci"},{"key":"2026020903164224900_bib11","doi-asserted-by":"publisher","first-page":"e79327","DOI":"10.1371\/journal.pone.0079327","article-title":"Potentiation of the effect of thiazide derivatives by carbonic anhydrase inhibitors: molecular mechanisms and potential clinical implications","volume":"8","author":"Zahedi","year":"2013","journal-title":"PLoS ONE"},{"key":"2026020903164224900_bib12","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1159\/000494596","article-title":"Slc4a8 in the kidney: expression, subcellular localization and role in salt reabsorption","volume":"50","author":"Xu","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"2026020903164224900_bib13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jchf.2019.01.007","article-title":"Natriuretic response is highly variable and associated with 6-month survival: insights from the ROSE-AHF trial","volume":"7","author":"Hodson","year":"2019","journal-title":"JACC: Heart Fail"},{"key":"2026020903164224900_bib14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/ejhf.1369","article-title":"The use of diuretics in heart failure with congestion\u2014a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"21","author":"Mullens","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2026020903164224900_bib15","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/0021-9681(55)90195-8","article-title":"A comparative study of neohydrin and diamox when used alone and in combination for the treatment of severe congestive heart failure","volume":"2","author":"Moyer","year":"1955","journal-title":"J Chronic Dis"},{"key":"2026020903164224900_bib16","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(56)90105-2","article-title":"Acetazolamide (diamox) in the treatment of congestive heart-failure","volume":"270","author":"Hanley","year":"1956","journal-title":"Lancet"},{"key":"2026020903164224900_bib17","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1478","article-title":"Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance","volume":"21","author":"Verbrugge","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2026020903164224900_bib18","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJMoa2203094","article-title":"Acetazolamide in acute decompensated heart failure with volume overload","volume":"387","author":"Mullens","year":"2022","journal-title":"N Engl J Med"},{"key":"2026020903164224900_bib19","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.0000000887","article-title":"Loop diuretic dose intensification versus adjuvant thiazide for diuretic resistance in acute heart failure: mechanistic randomized controlled trial","author":"Rao","year":"2025","journal-title":"J Am Soc Nephrol"},{"key":"2026020903164224900_bib20","doi-asserted-by":"publisher","first-page":"e009149","DOI":"10.1161\/JAHA.118.009149","article-title":"Outcomes associated with a strategy of adjuvant metolazone or high-dose loop diuretics in acute decompensated heart failure: a propensity analysis","volume":"7","author":"Brisco-Bacik","year":"2018","journal-title":"J Am Heart Associ"},{"key":"2026020903164224900_bib21","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/eurheartj\/ehac689","article-title":"CLOROTIC trial investigators. Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial","volume":"44","author":"Trull\u00e0s","year":"2023","journal-title":"Eur Heart J"},{"key":"2026020903164224900_bib22","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.jchf.2024.04.014","article-title":"Diuresis efficacy in ambulatory congested heart failure patients: intrapatient comparison of 3 diuretic regimens (DEA-HF)","volume":"12","author":"Abbo","year":"2024","journal-title":"JACC: Heart Fail"},{"key":"2026020903164224900_bib23","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.rec.2022.11.007","article-title":"CANDI study: chlorthalidone vs acetazolamide in patients with diuretic resistance in acute heart failure","volume":"76","author":"Vela Mart\u00edn","year":"2023","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edn)"},{"key":"2026020903164224900_bib24","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.amjmed.2014.12.020","article-title":"Substantial discrepancy between fluid and weight loss during acute decompensated heart failure treatment","volume":"128","author":"Testani","year":"2015","journal-title":"Am J Med"},{"key":"2026020903164224900_bib25","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1161\/CIRCULATIONAHA.123.064346","article-title":"Critical analysis of the effects of SGLT2 inhibitors on renal tubular sodium, water and chloride homeostasis and their role in influencing heart failure outcomes","volume":"148","author":"Packer","year":"2023","journal-title":"Circulation"},{"key":"2026020903164224900_bib26","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12882-019-1490-z","article-title":"Role of sodium\/glucose cotransporter inhibition on a rat model of angiotensin II-dependent kidney damage","volume":"20","author":"Reyes-Pardo","year":"2019","journal-title":"BMC Nephrol"},{"key":"2026020903164224900_bib27","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.jacc.2024.02.009","article-title":"Efficacy and safety of dapagliflozin in patients with acute heart failure","volume":"83","author":"Cox","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026020903164224900_bib28","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1161\/CIRCULATIONAHA.122.059038","article-title":"Effects of early empagliflozin initiation on diuresis and kidney function in patients with acute decompensated heart failure (EMPAG-HF)","volume":"146","author":"Schulze","year":"2022","journal-title":"Circulation"},{"key":"2026020903164224900_bib29","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","article-title":"Heart Failure Clinical Research Network. Ultrafiltration in decompensated heart failure with cardiorenal syndrome","volume":"367","author":"Bart","year":"2012","journal-title":"N Engl J Med"},{"key":"2026020903164224900_bib30","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1093\/eurheartj\/ehad236","article-title":"Pre-treatment bicarbonate levels and decongestion by acetazolamide: the ADVOR trial","volume":"44","author":"Martens","year":"2023","journal-title":"Eur Heart J"},{"key":"2026020903164224900_bib31","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1172\/JCI17443","article-title":"WNK kinases regulate thiazide-sensitive Na-Cl cotransport","volume":"111","author":"Yang","year":"2003","journal-title":"J Clin Invest"},{"key":"2026020903164224900_bib32","doi-asserted-by":"publisher","first-page":"4502","DOI":"10.1073\/pnas.1817220116","article-title":"WNK4 kinase is a physiological intracellular chloride sensor","volume":"116","author":"Chen","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026020903164224900_bib33","doi-asserted-by":"publisher","first-page":"ra41","DOI":"10.1126\/scisignal.2005050","article-title":"Chloride sensing by WNK1 involves inhibition of autophosphorylation","volume":"7","author":"Piala","year":"2014","journal-title":"Sci Signal"},{"key":"2026020903164224900_bib34","doi-asserted-by":"publisher","first-page":"e011749","DOI":"10.1161\/CIRCHEARTFAILURE.123.011749","article-title":"Serum chloride and the response to acetazolamide in patients with acute heart failure and volume overload: a post hoc analysis from the ADVOR trial","volume":"17","author":"Van den Eynde","year":"2024","journal-title":"Circ: Heart Fail"},{"key":"2026020903164224900_bib35","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/0002-9343(88)90091-5","article-title":"Side effects of acetazolamide: the champagne blues","volume":"84","author":"Graber","year":"1988","journal-title":"Am J Med"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfaf379\/65920408\/sfaf379.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/2\/sfaf379\/65920408\/sfaf379.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/2\/sfaf379\/65920408\/sfaf379.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T08:16:50Z","timestamp":1770625010000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfaf379\/8381410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfaf379","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,12,16]]},"article-number":"sfaf379"}}